Answer
Wegovy (semaglutide) is indicated alongside diet and exercise to treat non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis consistent with stages F2 to F3.
Sources for this answer
- Wegovy 2.4 mg, FlexTouch solution for injection in pre-filled penNovo Nordisk Limited · emc · SmPC §4.1 Therapeutic Indications · Version 16Document updated
Sources checked